Evaluation of Type 2 Diabetes Treatment

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

May 15, 2017

Study Completion Date

June 10, 2017

Conditions
Type2 Diabetes
Interventions
DRUG

Diabeton 60 MR

Administer Diabeton MR 60 mg 1/2 tablet. Increasing dosage of Diabeton MR 60 mg by ½ tablet is recommended if fasting glucose level exceeds 6 mmol/L.

Trial Locations (4)

AZ 1/122

Azerbaijan Republic Ministry of Health Republic Endocrinology Center, Baku

AZ 1025

Azer-Turk Med clinic, Baku

Hospital of oil workers, polyclinics and private clinics, Baku

AZ-1078

Medical Clinic of Azerbaijan Medical University, Baku

All Listed Sponsors
lead

Servier Affaires Médicales

INDUSTRY

NCT03164187 - Evaluation of Type 2 Diabetes Treatment | Biotech Hunter | Biotech Hunter